Thoracic NUT carcinoma: Common pathological features despite diversity of clinical presentations.


Journal

Lung cancer (Amsterdam, Netherlands)
ISSN: 1872-8332
Titre abrégé: Lung Cancer
Pays: Ireland
ID NLM: 8800805

Informations de publication

Date de publication:
08 2021
Historique:
received: 11 01 2021
revised: 03 06 2021
accepted: 06 06 2021
pubmed: 14 6 2021
medline: 4 8 2021
entrez: 13 6 2021
Statut: ppublish

Résumé

NUT carcinoma (NC), formerly known as NUT midline carcinoma, is a rare and very aggressive cancer. It is genetically defined by the presence of acquired chromosomal rearrangement of the NUTM1 (NUclear protein in Testis Midline carcinoma family member 1) gene at chromosome 15q14 with a member of the bromodomain-containing protein (BRD) family gene, usually BRD4. Although primarily reported in the head and neck, and mediastinum locations of younger individuals, it is now established that NC arises in multiple sites in patients of all ages, with no gender predilection. NC is very likely to be underdiagnosed because of a lack of awareness of both clinicians and pathologists on the one hand, and of a nonspecific histological presentation on the other hand. As it is indistinguishable from other poorly differentiated carcinomas, pathologists should consider NC as a differential diagnosis of any poorly differentiated tumour. Diagnosis is now easily made by immunohistochemistry, using a highly sensitive and specific NUT monoclonal antibody. Despite chemo- or chemo-radiotherapy, the prognosis of this tumour remains very poor. We report here a series of 3 cases of NC with different clinical and pathological presentations in order to draw attention on some common morphological features that can help clinicians and pathologists to think about this rare entity.

Identifiants

pubmed: 34119933
pii: S0169-5002(21)00435-9
doi: 10.1016/j.lungcan.2021.06.008
pii:
doi:

Substances chimiques

BRD4 protein, human 0
Cell Cycle Proteins 0
Nuclear Proteins 0
Oncogene Proteins 0
Transcription Factors 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

55-59

Informations de copyright

Copyright © 2021. Published by Elsevier B.V.

Auteurs

Amal Fekkar (A)

CHU Grenoble-Alpes, Department of Pathology, 38043, Grenoble, France.

Camille Emprou (C)

CHU Grenoble-Alpes, Department of Pathology, 38043, Grenoble, France; Univ Grenoble Alpes, CNRS UMR5309, Inserm U1209, Institute for Advanced Biosciences, F-38000, Grenoble, France.

Christine Lefebvre (C)

CHU Grenoble-Alpes, Laboratory of Hematology, 38043, Grenoble, France.

Gilbert Ferretti (G)

CHU Grenoble-Alpes, Department of Radiology, 38043, Grenoble, France; University of Grenoble Alpes, F-38000, Grenoble, France.

Olivier Stephanov (O)

CHU Grenoble-Alpes, Department of Pathology, 38043, Grenoble, France.

Daniel Pissaloux (D)

Centre Léon Bérard and CRCL, Department of Biopathology, 28 rue Laënnec, 69373, Lyon, France.

Anne Mc Leer (A)

CHU Grenoble-Alpes, Department of Pathology, 38043, Grenoble, France; Univ Grenoble Alpes, CNRS UMR5309, Inserm U1209, Institute for Advanced Biosciences, F-38000, Grenoble, France.

Anne-Claire Toffart (AC)

Univ Grenoble Alpes, CNRS UMR5309, Inserm U1209, Institute for Advanced Biosciences, F-38000, Grenoble, France; CHU Grenoble-Alpes, Department of Pneumology and Physiology, 38043, Grenoble, France.

Sophie Rousseaux (S)

Univ Grenoble Alpes, CNRS UMR5309, Inserm U1209, Institute for Advanced Biosciences, F-38000, Grenoble, France.

Saadi Khochbin (S)

Univ Grenoble Alpes, CNRS UMR5309, Inserm U1209, Institute for Advanced Biosciences, F-38000, Grenoble, France.

Sylvie Lantuejoul (S)

University of Grenoble Alpes, F-38000, Grenoble, France; Centre Léon Bérard and CRCL, Department of Biopathology, 28 rue Laënnec, 69373, Lyon, France.

Séverine Valmary-Degano (S)

CHU Grenoble-Alpes, Department of Pathology, 38043, Grenoble, France; Univ Grenoble Alpes, CNRS UMR5309, Inserm U1209, Institute for Advanced Biosciences, F-38000, Grenoble, France. Electronic address: svalmarydegano@chu-grenoble.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH